Cutler Group’s Cardlytics CDLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
Sell
-10
Closed -$8K 5418
2021
Q3
$8K Hold
10
﹤0.01% 4093
2021
Q2
$12K Hold
10
﹤0.01% 3728
2021
Q1
$10K Sell
10
-157
-94% -$207K ﹤0.01% 3789
2020
Q4
$238K Buy
167
+90
+117% +$96K 0.01% 987
2020
Q3
$54K Buy
+77
New +$56K ﹤0.01% 1747
2020
Q2
Sell
-220
Closed -$127K 4413
2020
Q1
$76K Buy
220
+70
+47% +$49.6K ﹤0.01% 1492
2019
Q4
$94K Buy
+150
New +$73.3K 0.01% 1233

Other funds holding CDLX

Cutler Group's CDLX Position: Q4 2021 in Review

Cutler Group sold out of Cardlytics (CDLX) in Q4 2021, closing a stake of 10 shares — an estimated $8K sold.

Cutler Group first reported a position in CDLX in Q4 2019 and held it in 7 quarters. The position peaked at $238K in Q4 2020. 163 funds tracked by Wall St. Rank hold CDLX as of Q4 2021.

  • Cutler Group reported no remaining Cardlytics position as of Q4 2021 after selling out during the quarter.
  • Cutler Group sold 10 Cardlytics shares in Q4 2021, an estimated $8K.
  • Cutler Group first reported a position in Cardlytics in Q4 2019 and held it in 7 quarters.
  • Cutler Group's Cardlytics position peaked at $238K in Q4 2020.
  • 163 funds tracked by Wall St. Rank held Cardlytics as of Q4 2021.

Based on Cutler Group's 13F filing for Q4 2021, filed 18 Jan 2022.